Session-aware quotes · provider delays vary · Not financial advice
BullishMEDIUM severityTech & AI24d ago

Castle Biosciences raises 2026 revenue guidance to $365M-$375M as TissueCypher volume trends toward 50%-52% growth

Reported by Seeking Alpha · seekingalpha.com · July 31, 2026

$CSTL
Bullish read

What the tape says

What to watch: CSTL (CSTL) raised guidance toward 50% — confirm the raise reflects durable demand, not a one-time item.

Amount
$365 million
Amount
$375 million
Change
50%
Change
-52%

Market reaction today: $CSTL -2.13%

Tone and severity are deterministic keyword classification — not a prediction, a member vote, or a recommendation. Figures are extracted from the headline as published. Wook does not republish Seeking Alpha's reporting.

Your read

Discussion

No one has weighed in yet. Start the discussion on this story.

More coverage on these names

Headline and link are attributed to Seeking Alpha. Wook of Wall Street is an independent research tool and is not affiliated with Seeking Alpha. Nothing here is financial advice or a recommendation — research and educational content only.